Dr. Carroll is a clinical assistant professor, Tulane University School of Medicine, and section head of Pediatric Hospital Medicine, Ochsner Health System, New Orleans, Louisiana.

The FDA acknowledged that the primary endpoint was met but that "data do not support the effectiveness of low-dose atropine in children with myopia," according to Sydnexis. FDA issued a complete ...

Combined or individual use of maternal RSVpreF and infant nirsevimab achieved high antibody levels without safety concerns, supporting current RSV prevention strategies. The prospective, randomized, ...

Yohei Doi, MD, IDWeek chair, Infectious Diseases Society of America, provides some insights on the happenings at this year’s event from Atlanta, Georgia. IDWeek 2025 has commenced, and with it comes ...

Indication expansions include hidradenitis suppurativa for patients 12 years and up, as well as for patients with uveitis aged 2 years and older. FDA approval extends adalimumab-aaty’s indications to ...